Stryker
3,153
$188.599876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$188.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.63 (+0.34%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Stryker and other stocks, options, ETFs, and crypto commission-free!
About SYK
Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. Read More The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
Employees
40,000
Headquarters
Kalamazoo, Michigan
Founded
1941
Market Cap
70.84B
Price-Earnings Ratio
44.96
Dividend Yield
1.19
Average Volume
1.55M
High Today
$188.66
Low Today
$185.26
Open Price
$187.28
Volume
1.50M
52 Week High
$226.30
52 Week Low
$124.54
Collections
SYK News
BenzingaAug 4
Global Spine Biologics Industry Outlook, 2025 with Profiles of Key Players Including DePuy Synthes, Orthofix Medical, Stryker, and Zimmer Biomet
Dublin, Aug. 04, 2020 (GLOBE NEWSWIRE) -- The "Global Spine Biologics Market: Growth, Trends and Forecasts (2020-2025)" report has been added to ResearchAndMark
Analyst Ratings
56%
of 27 ratings
Buy
56%
Hold
33%
Sell
11%
SYK Earnings
$0.55
$1.20
$1.84
$2.49
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
$0.55 per share
Actual
$0.64 per share